Sarepta Therapeutics (SRPT) Q2 2017 Earnings

27AprConfirmed
Q3 2016
Q4 2016
Q1 2017
Q2 2017
-1.38
-1
-0.62
-0.24

Details

Expected EPS
-0.24
Actual EPS
-0.71
Surprise EPS
-0.47
Surprise Percent
+195.83%

Description

Sarepta Therapeutics (SRPT) has reported earnings of -0.71 per share for Q2 2017.

0 Comments

Share your thoughts